Impact of perioperative chemotherapy on postoperative morbidity after gastrectomy for gastric cancer
Introduction: The use of perioperative chemotherapy (CT) in patients with advanced gastric carcinoma increases their overall survival. This therapy may also increase the number of patients with R0 resection. Potential drawbacks of this therapy, besides its toxicity, include increased surgical morbid...
Autor principal: | |
---|---|
Outros Autores: | , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2021
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.21/13816 |
País: | Portugal |
Oai: | oai:repositorio.ipl.pt:10400.21/13816 |